Skip to content

An Islamic Psychospiritual-Acceptance and Commitment-based Prevention Program for At-risk Young Adults in the COVID-19 Pandemic

An Islamic Psychospiritual-Acceptance and Commitment-based Prevention Program for At-Risk Young Adults in the COVID-19 Pandemic

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04870385
Enrollment
120
Registered
2021-05-03
Start date
2021-04-11
Completion date
2021-08-31
Last updated
2021-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychological Distress

Keywords

Acceptance and Commitment Therapy (ACT), Islamic psychospiritual intervention, Online intervention, COVID-19, Prevention program

Brief summary

The COVID-19 pandemic has increased mental health concerns worldwide, and young adults are at higher risk of experiencing increased psychological distress due to the pandemic. University students face compounding stressors during the pandemic, such as online and remote learning, economic insecurity, and uncertain career prospects. This study aims to evaluate the effectiveness of an online modular prevention program featuring integrated elements of Acceptance and Commitment Therapy (ACT) and Islamic spirituality in reducing the psychological distress and increasing the psychological flexibility, self-compassion, and resilience of Muslim university students in Malaysia.

Interventions

BEHAVIORAL5-week prevention program

Online modular psychological prevention program featuring integrated elements of Islamic spirituality and Acceptance and Commitment Therapy (ACT).

BEHAVIORALControl

Control group waitlisted to receive prevention program after completion of final data collection.

Sponsors

International Institute of Islamic Thought
CollaboratorUNKNOWN
International Islamic University Malaysia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

A randomised parallel interventional study model in which there will be 2 groups, an intervention group and a waitlist control group.

Eligibility

Sex/Gender
ALL
Age
18 Years to 29 Years
Healthy volunteers
Yes

Inclusion criteria

* Undergraduate or postgraduate student enrolled in a Malaysian university * aged 18-29 years old * Obtained moderate and above levels in either one of the stress, anxiety, and depression subscales of the DASS-21 pre-intervention assessment * Muslim * Owns a gadget with Internet access * Can read and understand English

Exclusion criteria

* Those with previous experience with a modular ACT-based treatment with Islamic elements * Those with past or present diagnosis of mental/neurological disorder * Those reporting active suicidality * Those involved in any other form of psychological treatment (ie. psychotherapy, pharmacotherapy)

Design outcomes

Primary

MeasureTime frameDescription
Changes in psychological distressMeasured at pre-intervention, mid-intervention (third week of prevention program), post-intervention (up to 1-week after completion of program), and 1-month follow-upMeasured using the Depression, Anxiety, and Stress Scale (DASS-21; Lovibond & Lovibond, 1995).

Secondary

MeasureTime frameDescription
Changes in psychological flexibilityMeasured at pre-intervention, mid-intervention (third week of prevention program), post-intervention (up to 1-week after completion of program), and 1-month follow-upMeasured using the Acceptance and Action Questionnaire (AAQ-II; Bond et al., 2011; Hayes et al., 2004).
Changes in self-compassion.Measured at pre-intervention, mid-intervention (third week of prevention program), post-intervention (up to 1-week after completion of program), and 1-month follow-upMeasured through the Self-Compassion Scale (SCS; Neff 2003; Neff, 2015).
Changes in resilienceMeasured at pre-intervention, mid-intervention (third week of prevention program), post-intervention (up to 1-week after completion of program), and 1-month follow-upMeasured by the Brief Resilience Scale (BRS; Smith et al., 2008).

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026